These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 1642153

  • 1. Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption.
    Yates AJ, Boyce BF, Favarato G, Aufdemorte TB, Marcelli C, Kester MB, Walker R, Langton BC, Bonewald LF, Mundy GR.
    J Bone Miner Res; 1992 Jul; 7(7):847-53. PubMed ID: 1642153
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL, Mundy GR, Boyce BF, Story BM, Dunstan CR, Yin JJ, Roodman GD, Guise TA.
    Cancer Res; 1997 Aug 01; 57(15):3194-9. PubMed ID: 9242449
    [Abstract] [Full Text] [Related]

  • 3. Chinese hamster ovarian cells transfected with human parathyroid hormone-related protein cDNA cause hypercalcemia in nude mice.
    Guise TA, Chirgwin JM, Favarato G, Boyce BF, Mundy GR.
    Lab Invest; 1992 Oct 01; 67(4):477-85. PubMed ID: 1434529
    [Abstract] [Full Text] [Related]

  • 4. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro.
    Guise TA, Yoneda T, Yates AJ, Mundy GR.
    J Clin Endocrinol Metab; 1993 Jul 01; 77(1):40-5. PubMed ID: 8325957
    [Abstract] [Full Text] [Related]

  • 5. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
    Yoneda T, Williams P, Rhine C, Boyce BF, Dunstan C, Mundy GR.
    Cancer Res; 1995 May 01; 55(9):1989-93. PubMed ID: 7728770
    [Abstract] [Full Text] [Related]

  • 6. Increased production of tumor necrosis factor by normal immune cells in a model of the humoral hypercalcemia of malignancy.
    Sabatini M, Yates AJ, Garrett IR, Chavez J, Dunn JF, Bonewald L, Mundy GR.
    Lab Invest; 1990 Nov 01; 63(5):676-82. PubMed ID: 2232714
    [Abstract] [Full Text] [Related]

  • 7. Importance of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vivo.
    Kurachi H, Morishige K, Amemiya K, Adachi H, Hirota K, Miyake A, Tanizawa O.
    Cancer Res; 1991 Nov 01; 51(21):5956-9. PubMed ID: 1933859
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.
    Oyajobi BO, Anderson DM, Traianedes K, Williams PJ, Yoneda T, Mundy GR.
    Cancer Res; 2001 Mar 15; 61(6):2572-8. PubMed ID: 11289133
    [Abstract] [Full Text] [Related]

  • 9. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.
    de la Mata J, Uy HL, Guise TA, Story B, Boyce BF, Mundy GR, Roodman GD.
    J Clin Invest; 1995 Jun 15; 95(6):2846-52. PubMed ID: 7769125
    [Abstract] [Full Text] [Related]

  • 10. Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice.
    Johnson RA, Boyce BF, Mundy GR, Roodman GD.
    Endocrinology; 1989 Mar 15; 124(3):1424-7. PubMed ID: 2917519
    [Abstract] [Full Text] [Related]

  • 11. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
    Sato K, Yamakawa Y, Shizume K, Satoh T, Nohtomi K, Demura H, Akatsu T, Nagata N, Kasahara T, Ohkawa H.
    J Bone Miner Res; 1993 Jul 15; 8(7):849-60. PubMed ID: 8352067
    [Abstract] [Full Text] [Related]

  • 12. Copurification of osteolytic and transforming growth factor beta activities produced by human lung tumor cells associated with humoral hypercalcemia of malignancy.
    Linkhart TA, Mohan S, Jennings JC, Baylink DJ.
    Cancer Res; 1989 Jan 15; 49(2):271-8. PubMed ID: 2535957
    [Abstract] [Full Text] [Related]

  • 13. Over-expression of transforming growth factor alpha antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cell.
    Baselga J, Maerz WJ, Moy D, Miller WH, Castro L, Reuter VE, Yao TJ, Masui H, Dmitrovsky E.
    Oncogene; 1993 Dec 15; 8(12):3257-63. PubMed ID: 8247529
    [Abstract] [Full Text] [Related]

  • 14. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
    Lerner UH.
    J Bone Miner Res; 1996 Nov 15; 11(11):1628-39. PubMed ID: 8915770
    [Abstract] [Full Text] [Related]

  • 15. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
    Wu JC, Merlino G, Cveklova K, Mosinger B, Fausto N.
    Cancer Res; 1994 Nov 15; 54(22):5964-73. PubMed ID: 7525051
    [Abstract] [Full Text] [Related]

  • 16. The role of transforming growth factor alpha in determining growth factor independence.
    Awwad RA, Sergina N, Yang H, Ziober B, Willson JK, Zborowska E, Humphrey LE, Fan R, Ko TC, Brattain MG, Howell GM.
    Cancer Res; 2003 Aug 01; 63(15):4731-8. PubMed ID: 12907656
    [Abstract] [Full Text] [Related]

  • 17. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
    Dlugosz AA, Cheng C, Williams EK, Darwiche N, Dempsey PJ, Mann B, Dunn AR, Coffey RJ, Yuspa SH.
    Cancer Res; 1995 May 01; 55(9):1883-93. PubMed ID: 7728756
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
    Phillips PC, Levow C, Catterall M, Colvin OM, Pastan I, Brem H.
    Cancer Res; 1994 Feb 15; 54(4):1008-15. PubMed ID: 8313355
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of tumor growth in liver epithelial cells transfected with a transforming growth factor alpha antisense gene.
    Laird AD, Brown PI, Fausto N.
    Cancer Res; 1994 Aug 01; 54(15):4224-32. PubMed ID: 8033155
    [Abstract] [Full Text] [Related]

  • 20. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB.
    Cell Growth Differ; 1995 Jun 01; 6(6):737-48. PubMed ID: 7669729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.